1. Home
  2. PAI vs ATRA Comparison

PAI vs ATRA Comparison

Compare PAI & ATRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Western Asset Investment Grade Income Fund Inc.

PAI

Western Asset Investment Grade Income Fund Inc.

N/A

Current Price

$11.30

Market Cap

114.7M

Sector

Finance

ML Signal

N/A

Logo Atara Biotherapeutics Inc.

ATRA

Atara Biotherapeutics Inc.

N/A

Current Price

$9.41

Market Cap

94.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PAI
ATRA
Founded
1973
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Trusts Except Educational Religious and Charitable
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
114.7M
94.2M
IPO Year
N/A
2014

Fundamental Metrics

Financial Performance
Metric
PAI
ATRA
Price
$11.30
$9.41
Analyst Decision
Buy
Analyst Count
0
3
Target Price
N/A
★ $13.67
AVG Volume (30 Days)
21.9K
★ 33.1K
Earning Date
01-01-0001
11-11-2026
Dividend Yield
★ 4.78%
N/A
EPS Growth
N/A
★ 122.52
EPS
★ N/A
N/A
Revenue
N/A
★ $120,772,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$1,334.59
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$11.25
$3.92
52 Week High
$12.95
$19.15

Technical Indicators

Market Signals
Indicator
PAI
ATRA
Relative Strength Index (RSI) 26.56 54.10
Support Level N/A $8.96
Resistance Level $12.35 $10.02
Average True Range (ATR) 0.08 0.67
MACD -0.01 0.07
Stochastic Oscillator 15.29 85.20

Price Performance

Historical Comparison
PAI
ATRA

About PAI Western Asset Investment Grade Income Fund Inc.

Western Asset Investment Grade Income Fund Inc is a closed-end diversified investment company. Its primary investment objective is to seek a high level of current income, consistent with prudent investment risk, through investment in a diversified portfolio of debt securities. To a lesser extent, the fund also invests in privately placed debt securities and in certain equity securities. Capital appreciation is its secondary investment objective. The fund invests a majority of its net assets in fixed income securities that are rated in the Baa or BBB categories or above at the time of purchase by one or more Nationally Recognized Statistical Rating Organizations (NRSROs) or unrated securities of comparable quality at the time of purchase (as determined by the investment adviser).

About ATRA Atara Biotherapeutics Inc.

Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA3431, and ATA3219.

Share on Social Networks: